We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH: Expect More IDE Support With Push for U.S. Clinical Trials
CDRH: Expect More IDE Support With Push for U.S. Clinical Trials
The FDA’s decision to make growth in U.S. clinical trials a high priority is leading to new guidances, shortened approval waits on IDEs and a new position dedicated to handling device trial issues.